SG Americas Securities’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-134,765
| Closed | -$449K | – | 2819 |
|
|
2025
Q1 | $449K | Buy |
134,765
+65,140
| +94% | +$217K | ﹤0.01% | 1677 |
|
|
2024
Q4 | $515K | Buy |
+69,625
| New | +$515K | ﹤0.01% | 1143 |
|
|
2024
Q3 | – | Sell |
-498,390
| Closed | -$4M | – | 3049 |
|
|
2024
Q2 | $4M | Buy |
498,390
+445,172
| +837% | +$3.57M | 0.02% | 607 |
|
|
2024
Q1 | $789K | Sell |
53,218
-35,511
| -40% | -$526K | ﹤0.01% | 1117 |
|
|
2023
Q4 | $721K | Sell |
88,729
-187,664
| -68% | -$1.52M | 0.01% | 1109 |
|
|
2023
Q3 | $1.26M | Sell |
276,393
-91,074
| -25% | -$415K | 0.01% | 1009 |
|
|
2023
Q2 | $2.59M | Buy |
+367,467
| New | +$2.59M | 0.02% | 565 |
|
|
2022
Q3 | – | Sell |
-81,549
| Closed | -$900K | – | 2951 |
|
|
2022
Q2 | $900K | Sell |
81,549
-149,528
| -65% | -$1.65M | 0.01% | 1247 |
|
|
2022
Q1 | $3.85M | Buy |
231,077
+225,452
| +4,008% | +$3.75M | 0.03% | 462 |
|
|
2021
Q4 | $107K | Sell |
5,625
-13,103
| -70% | -$249K | ﹤0.01% | 2756 |
|
|
2021
Q3 | $462K | Sell |
18,728
-3,943
| -17% | -$97.3K | ﹤0.01% | 2375 |
|
|
2021
Q2 | $590K | Sell |
22,671
-318
| -1% | -$8.28K | ﹤0.01% | 1688 |
|
|
2021
Q1 | $728K | Buy |
22,989
+15,458
| +205% | +$490K | ﹤0.01% | 1589 |
|
|
2020
Q4 | $349K | Sell |
7,531
-28,602
| -79% | -$1.33M | ﹤0.01% | 1985 |
|
|
2020
Q3 | $1.19M | Buy |
36,133
+29,560
| +450% | +$973K | 0.01% | 888 |
|
|
2020
Q2 | $180K | Sell |
6,573
-20,633
| -76% | -$565K | ﹤0.01% | 2544 |
|
|
2020
Q1 | $814K | Buy |
27,206
+5,690
| +26% | +$170K | 0.01% | 1153 |
|
|
2019
Q4 | $596K | Buy |
21,516
+1,825
| +9% | +$50.6K | 0.01% | 1409 |
|
|
2019
Q3 | $358K | Sell |
19,691
-115,410
| -85% | -$2.1M | ﹤0.01% | 1782 |
|
|
2019
Q2 | $3.31M | Buy |
135,101
+65,832
| +95% | +$1.61M | 0.02% | 669 |
|
|
2019
Q1 | $659K | Buy |
69,269
+48,968
| +241% | +$466K | 0.01% | 1399 |
|
|
2018
Q4 | $180K | Buy |
+20,301
| New | +$180K | ﹤0.01% | 2073 |
|
|
2018
Q3 | – | Sell |
-9,116
| Closed | -$117K | – | 2730 |
|
|
2018
Q2 | $117K | Sell |
9,116
-3,660
| -29% | -$47K | ﹤0.01% | 2589 |
|
|
2018
Q1 | $216K | Buy |
+12,776
| New | +$216K | ﹤0.01% | 2023 |
|
|
2017
Q4 | – | Sell |
-50,295
| Closed | -$390K | – | 2759 |
|
|
2017
Q3 | $390K | Buy |
50,295
+39,931
| +385% | +$310K | ﹤0.01% | 1766 |
|
|
2017
Q2 | $76K | Sell |
10,364
-495
| -5% | -$3.63K | ﹤0.01% | 2582 |
|
|
2017
Q1 | $81K | Sell |
10,859
-12,662
| -54% | -$94.4K | ﹤0.01% | 2685 |
|
|
2016
Q4 | $163K | Buy |
+23,521
| New | +$163K | ﹤0.01% | 2218 |
|
|
2015
Q4 | – | Sell |
-10,578
| Closed | -$61K | – | 2317 |
|
|
2015
Q3 | $61K | Buy |
+10,578
| New | +$61K | ﹤0.01% | 1946 |
|